EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue3,435,3002,963,7002,493,700
Cost of Revenue875,300797,400617,200
Gross Profit2,560,0002,166,3001,876,500
Operating Expenses
Research Development552,600442,200382,900
Selling General and Administrative1,034,700940,300850,900
Non Recurring-73,30032,6007,000
Total Operating Expenses---
Operating Income or Loss1,046,000751,200635,700
Income from Continuing Operations
Total Other Income/Expenses Net12,1005,9003,900
Earnings Before Interest and Taxes1,058,100757,100639,600
Interest Expense23,20019,20017,200
Income Before Tax1,034,900737,900622,400
Income Tax Expense451,300168,400127,500
Minority Interest---
Net Income From Continuing Ops583,600569,500494,900
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income583,600569,500494,900
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares583,600569,500494,900